Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of DTFC, LTFC, and Adjunctive Therapy in Glaucoma
NCT00397241Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Sep 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dorzolamide + timolol in open-angle glaucoma (OAG) and pseudoexfoliative glaucoma (PEXG), sponsored by Aristotle University of Thessaloniki. Primary endpoints: 24-hour Intraocular Pressure Control (DTFC vs LTFC) at 3 months and 24-hour Intraocular Pressure Control (Adjunctive vs Fixed Combinations) at 3 months. Started Sep 2006; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
open-angle glaucoma (OAG)pseudoexfoliative glaucoma (PEXG)
Beyond the preview
Go deeper on NCT00397241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397241.